Metastatic breast lobular carcinoma involving tamoxifen-associated endometrial polyps: Report of two cases and review of tamoxifen-associated polypoid uterine lesions

Modern Pathology

Volumn 16, Issue 4, 2003, Pages 395-398

  Houghton, J P ^a   Ioffe, O B ^b   Silverberg, S G ^b   McGrady, B ^c   McCluggage, W G ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c Royal Victoria Hospitals Trust   (United Kingdom)

Author keywords

Endometrium; Metastatic breast carcinoma; Polyp; Tamoxifen

Indexed keywords

TAMOXIFEN;

AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CASE REPORT; CLINICAL FEATURE; CURETTAGE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM TUMOR; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYSTEROSCOPY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MASTECTOMY; METASTASIS; POLYP; PRIORITY JOURNAL; UTERUS BLEEDING;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA, LOBULAR; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MIDDLE AGED; POLYPS; TAMOXIFEN;

EID: 0345790143     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000062655.62606.86     Document Type: Article

References (32)

1. Early Breast Cancer Trialists' Collaborative Group. Systematic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet 1992;339:1-15.
2. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998;351:1451-67.
3. Wakeling AE, Bowler J. Biology and mode of action of pure antiestrogens. J Steroid Biochem 1988;30:141-7.
4. Ismail SM. Pathology of endometrium treated with tamoxifen. J Clin Pathol 1994;47:827-33.
5. Neven P, De Muylder X, Van Belle Y, Venderick G, De Muylder E. Tamoxifen and the uterus and endometrium. Lancet 1989;1:375.
6. Schlesinger C, Kamoi S, Ascher SM, Kendall M, Lage JM, Silverberg SG. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups. Int J Gynecol Pathol 1998;17:302-11.
7. Ferrazzi E, Cartei G, Mattarazzo R, et al. Oestrogen-like effect of tamoxifen on vaginal epithelium. BMJ 1997;1:1351-2.
8. Eells TP, Alpern HD, Gzywacz C, et al. The effect of tamoxifen on cervical squamous maturation in Papanicolaou stained cervical smears of postmenopausal women. Cytopathology 1990;1:263-8.
9. Cohen I, Beyth Y, Shapira J. High prevalence of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen. Gynecol Obstet Invest 1997;44:200-5.
10. McCluggage WG, Desai V, Manek S. Tamoxifen-associated postmenopausal adenomyosis exhibits stromal fibrosis, glandular dilatation and epithelial metaplasias. Histopathology 2000;37:340-6.
11. McCluggage WG, Bryson C, Lamki H, Boyle DD. Benign, borderline and malignant endometrioid neoplasia arising in endometriosis in association with tamoxifen therapy. Int J Gynecol Pathol 2000;19:276-9.
12. Cohen I, Altaras MM, Lew S, et al. Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature. Gynecol Oncol 1994;55:443-7.
13. Schlesinger C, Silverberg SG. Tamoxifen-associated polyps (basalomas) arising in multiple endometriotic foci: a case report and review of the literature. Gynecol Oncol 1999;73:305-11.
14. Kumar NB, Hart WR. Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases. Cancer 1982;50:2163-9.
15. Mazur MT, Hsueh S, Gersell DJ. Metastases to the female genital tract. Analysis of 325 cases. Cancer 1984;53:1978-84.
16. Aranda FI, Laforga JB, Martinez MA. Metastasis from breast lobular carcinoma to an endometrial polyp. Acta Obstet Gynecol Scand 1993;72:585-7.
17. Lambot MA, Eddafali B, Simon P, Fayt I, Noel JC. Metastasis from apocrine carcinoma of the breast to an endometrial polyp. Virchows Arch 2001;438:517-8.
18. Sullivan LG, Sullivan JL, Fairey WF. Breast carcinoma metastatic to endometrial polyp. Gynecol Oncol 1990;39:96-8.
19. Silva EG, Jenkins R. Serous carcinoma in endometrial polyps. Mod Pathol 1990;3:120-8.
20. Carcangia ML, Tom LK, Chambers IT. Stage IA uterine serous carcinoma: a study of 13 cases. Am J Surg Pathol 1997;21:1507-14.
21. Wheeler DT, Bell KA, Kurman RJ, Sherman ME. Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. Am J Surg Pathol 2000;24:797-806.
22. McCluggage WG, Sumathi VP, McManus DT. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of five cases including two associated with tamoxifen therapy. Hum Pathol (in press).
23. Silva EG, Tornos CS, Follen-Mitchell M. Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen. Int J Gynecol Pathol 1994;13:248-58.
24. McCluggage WG, Abdulkader M, Price JH, et al. Uterine carcinosarcomas in patients receiving tamoxifen. A report of 19 cases. Int J Gynecol Cancer 2000;10:280-4.
25. McCluggage WG, McManus DT, Lioe TF, Hill CH. Uterine carcinosarcoma in association with tamoxifen therapy. Br J Obstet Gynaecol 1997;104:748-50.
26. Evans MJ, Langlois NEI, Kitchener HC, Miller ID. Is there an association between long term tamoxifen treatment and the development of carcinosarcoma (malignant mixed Müllerian tumor) of the uterus? Int J Gynecol Cancer 1995:5:310-3.
27. Clement PB, Oliva E, Young RH. Müllerian adenosarcoma of the uterine corpus associated with tamoxifen therapy. A report of six cases and a review of tamoxifen-associated endometrial lesions. Int J Gynecol Pathol 1996;15:222-9.
28. Huang KT, Chen CA, Cheng WF, et al. Sonographic characteristics of adenofibroma of the endometrium following tamoxifen therapy for breast cancer: two case reports. Ultrasound Obstet Gynecol 1996;7:363-6.
29. Pang LC. Endometrial stromal sarcoma with sex cord-like differentiation associated with tamoxifen therapy. South Med J 1998;91:592-4.
30. McCluggage WG, Varma M, Weir P, Bharucha H. Uterine leiomyosarcoma in patient receiving tamoxifen therapy. Acta Obstet Gynecol Scand 1996;75:593-5.
31. Dilts PV, Hopkins MP, Cheng AK, Cody RL. Rapid growth of leiomyoma in patient receiving tamoxifen. Am J Obstet Gynecol 1992;166:167-8.
32. Leo L, Lanza A, Tessarolo RM, Bellino R, Lauricella A, Wierdis T. Leiomyomas in patients receiving tamoxifen. Clin Exp Obstet Gynecol 1994;21:94-8.